Announced Fri, 19 Jun · 15:35 IST
MD Shri Umesh Sandu (Promoter) passes away
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹42.77
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.0-1.9-3.2-3.4-4.1-4.1-5.3-4.1——
Up moveDown movePending
AI summary
Shri Umesh Sandu, Promoter and Managing Director of Sandu Pharmaceuticals, passed away on 19 June 2026. He held 13,88,693 shares (about 13.88 lakh) in the company. With his demise, the company loses its MD and a member of the Audit Committee and Stakeholders Relationship Committee. No successor has been named yet. The board has conveyed condolences to the family.
Likely market impact
Loss of promoter-MD creates leadership vacuum and governance uncertainty; no successor announced. Watch for board changes.